JavaScript is disabled for your browser. Some features of this site may not work without it.

    Listar

    Todo RIUMAComunidades & ColeccionesPor fecha de publicaciónAutoresTítulosMateriasTipo de publicaciónCentrosDepartamentos/InstitutosEditores

    Mi cuenta

    AccederRegistro

    Estadísticas

    Ver Estadísticas de uso

    DE INTERÉS

    Datos de investigaciónReglamento de ciencia abierta de la UMAPolítica de RIUMAPolitica de datos de investigación en RIUMAOpen Policy Finder (antes Sherpa-Romeo)Dulcinea
    Preguntas frecuentesManual de usoContacto/Sugerencias
    Listar por autor 
    •   RIUMA Principal
    • Listar por autor
    •   RIUMA Principal
    • Listar por autor

    Listar por autor "García-León, Juan Antonio"

    • 0-9
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • U
    • V
    • W
    • X
    • Y
    • Z

    Ordenar por:

    Orden:

    Resultados:

    Mostrando ítems 21-31 de 31

    • título
    • fecha de publicación
    • fecha de envío
    • ascendente
    • descendente
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
      • Kinetics and incidence of anti-natalizumab antibodies in multiple sclerosis patients on treatment for 18 months 

        Oliver-Martos, BegoñaAutoridad Universidad de Málaga; Fernández Fernández, Óscar; Órpez, Teresa; Alvarenga, Marcos Papais; Pinto-Medel, Mª Jesús; Guerrero, Miguel; León, Antonio; López-Madrona, José Carlos; Maldonado-Sánchez, Rafael; García-León, Juan AntonioAutoridad Universidad de Málaga; Luque, Gloria; Fernández Sánchez, Victoria Eugenia; Leyva-Fernández, LauraAutoridad Universidad de Málaga[et al.] (SAGE Journals, 2011)
        Natalizumab is a monoclonal antibody shown to be highly effective in the treatment of relapsing–remitting multiple sclerosis (RRMS). Patients treated with natalizumab can develop antibodies directed against this agent that ...
      • Kinetics and incidence of anti-natalizumab antibodies in multiple sclerosis patients on treatment for 18 months. 

        Oliver-Martos, BegoñaAutoridad Universidad de Málaga; Fernández, Óscar; Orpez, Teresa; Alvarenga, Marco Papais; Pinto-Medel, María Jesús; Guerrero, Miguel; León, Antonio; López-Madrona, José Carlos; Maldonado-Sánchez, Rafael; García-León, Juan AntonioAutoridad Universidad de Málaga; Luque, Gloria; Fernández, Victoria; Leyva-Fernández, LauraAutoridad Universidad de Málaga[et al.] (SAGE, 2011-03)
        Natalizumab is a monoclonal antibody shown to be highly effective in the treatment of relapsing-remitting multiple sclerosis (RRMS). Patients treated with natalizumab can develop antibodies directed against this agent that ...
      • Monocyte-derived cells invade brain parenchyma and amyloid plaques in human Alzheimer’s disease hippocampus. 

        Muñoz-Castro, Clara; Mejías-Ortega, Marina; Sánchez-Mejías, ElisabethAutoridad Universidad de Málaga; Navarro, Victoria; Trujillo-Estrada, Laura IsabelAutoridad Universidad de Málaga; Jimenez, Sebastian; García-León, Juan AntonioAutoridad Universidad de Málaga; Fernández-Valenzuela, Juan José; Sanchez-Mico, María Virtudes; Romero-Molina, Carmen; Moreno-González, Inés; Baglietto-Vargas, David; Marisa, Vizuete; Gutiérrez-Pérez, AntoniaAutoridad Universidad de Málaga; Vitorica Ferrández, Javier[et al.] (Biomed Central Ltd, 2023-02-28)
        Microglia play a major role in the innate immune responses of the CNS and the pathogenesis of Alzheimer’s disease (AD). However, the contribution of nonparenchymal or brain‑infiltrated myeloid cells to disease progression ...
      • Neurons and astrocytes derived from human iPSCs to model Alzheimer´s disease 

        Cáceres Palomo, Laura; Trujillo Estrada, Laura; López Oliva, Elba; Vitorica Ferrández, Javier; Gutiérrez-Pérez, AntoniaAutoridad Universidad de Málaga; García-León, Juan AntonioAutoridad Universidad de Málaga[et al.] (2023)
        Alzheimer's disease (AD) is characterized by presenting a complex pathology, not fully resolved yet. This fact, together with the lack of reliable models, has impeded the development of effective therapies. Recently, several ...
      • SOX10 Single Transcription Factor-Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells. 

        García-León, Juan AntonioAutoridad Universidad de Málaga; Kumar, Manoj; Boon, Ruben; Chau, David; One, Jennifer; Wolfs, Esther; Eggermont, Kristel; Berckmans, Pieter; Gunhanlar, Nilhan; de Vrij, Femke; Lendemeijer, Bas; Pavie, Benjamin; Corthout, Nikky; Kushner, Steven A; Dávila-Cansino, José CarlosAutoridad Universidad de Málaga; Lambrichts, Ivo; Hu, Wei-Shou; Verfaillie, Catherine M[et al.] (Elsevier, 2018-02)
        Scarce access to primary samples and lack of efficient protocols to generate oligodendrocytes (OLs) from human pluripotent stem cells (hPSCs) are hampering our understanding of OL biology and the development of novel ...
      • Stem Cell-Derived Oligodendroglial Cells for Therapy in Neurological Diseases. 

        García-León, Juan AntonioAutoridad Universidad de Málaga; Verfaillie, Catherine M. (Bentham Science, 2016-07)
        There are an important number of neurological diseases where not neurons but glia are the responsible cells for the degeneration of the nervous system. In the last years, determinant roles for oligodendrocytes (OLs) have ...
      • Suitability of human-derived cells as a platform for Alzheimer's disease modeling 

        Cáceres Palomo, Laura; García-León, Juan AntonioAutoridad Universidad de Málaga; Dávila-Cansino, José CarlosAutoridad Universidad de Málaga; Vitorica Ferrández, Javier; Gutiérrez-Pérez, AntoniaAutoridad Universidad de Málaga (2021)
        Aims: Alzheimer's disease (AD) is characterized by presenting a complex pathology, not fully resolved yet. This fact, together with the lack of reliable models, has impeded the development of effective therapies. Recently, ...
      • The CD4+ T-cell subset lacking expression of the CD28 costimulatory molecule is expanded and shows a higher activation state in multiple sclerosis. 

        Pinto-Medel, María Jesús; García-León, Juan AntonioAutoridad Universidad de Málaga; Oliver-Martos, BegoñaAutoridad Universidad de Málaga; López-Gómez, Carlos; Luque, Gloria; Arnáiz-Urrutia, Carlos; Órpez, Teresa; Marín-Bañasco, Carmen; Fernández Fernández, Óscar; Leyva-Fernández, LauraAutoridad Universidad de Málaga[et al.] (Elsevier, 2012-01-18)
        Multiple sclerosis (MS) is a chronic debilitating disease, in which T-cells are considered to play a pivotal role. CD28 is the quintessential costimulatory molecule on T-cells and its expression declines progressively ...
      • TRAIL/TRAIL receptor system and susceptibility to multiple sclerosis 

        López-Gómez, Carlos; Fernández, Oscar; García-León, Juan AntonioAutoridad Universidad de Málaga; Pinto-Medel, María Jesús; Oliver-Martos, BegoñaAutoridad Universidad de Málaga; Ortega-Pinazo, Jesús; Suardíaz-García, Margarita; García-Trujillo, Lucía; Guijarro-Castro, Cristina; Benito-León, Julián; Prat, Isidro; Varadé, Jezabel; Alvarez-Lafuente, Roberto; Urcelay, Elena; Leyva-Fernández, LauraAutoridad Universidad de Málaga[et al.] (Public Library of Science, 2011-07)
        The TNF-related apoptosis inducing ligand (TRAIL)/TRAIL receptor system participates in crucial steps in immune cell activation or differentiation. It is able to inhibit proliferation and activation of T cells and to induce ...
      • Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis 

        Sánchez-Varo, Raquel MaríaAutoridad Universidad de Málaga; Mejías-Ortega, Marina; Fernández-Valenzuela, Juan José; Núñez-Díaz, Cristina; Cáceres Palomo, Laura; Vegas-Gómez, Laura; Sánchez-Mejías, ElisabethAutoridad Universidad de Málaga; Trujillo-Estrada, Laura IsabelAutoridad Universidad de Málaga; Moreno-González, Inés; García-León, Juan AntonioAutoridad Universidad de Málaga; Vizuete, María Luisa; Vitorica Ferrández, Javier; Baglietto-Vargas, David; Gutiérrez-Pérez, AntoniaAutoridad Universidad de Málaga[et al.] (IOAP-MPDI, 2022-05-12)
        Alzheimer’s disease (AD) constitutes the most prominent form of dementia among elderly individuals worldwide. Disease modeling using murine transgenic mice was first initiated thanks to the discovery of heritable mutations ...
      • Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform 

        García-León, Juan AntonioAutoridad Universidad de Málaga; Vitorica Ferrández, Javier; Gutiérrez-Pérez, AntoniaAutoridad Universidad de Málaga (Taylor and Francis, 2019-06)
        Most neurodegenerative diseases are characterized by a complex and mostly still unresolved pathology. This fact, together with the lack of reliable disease models, has precluded the development of effective therapies ...
        REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
        REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
         

         

        REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
        REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA